30 related articles for article (PubMed ID: 32374603)
1. An unexpected switch in peptide binding mode: from simulation to substrate specificity.
Kahler U; Fuchs JE; Goettig P; Liedl KR
J Biomol Struct Dyn; 2018 Nov; 36(15):4072-4084. PubMed ID: 29210603
[TBL] [Abstract][Full Text] [Related]
2. Crystal structures of the complex of a kallikrein inhibitor from Bauhinia bauhinioides with trypsin and modeling of kallikrein complexes.
Li M; Srp J; Gustchina A; Dauter Z; Mares M; Wlodawer A
Acta Crystallogr D Struct Biol; 2019 Jan; 75(Pt 1):56-69. PubMed ID: 30644845
[TBL] [Abstract][Full Text] [Related]
3. Discovery, Synthesis, Pharmacological Profiling, and Biological Characterization of Brintonamides A-E, Novel Dual Protease and GPCR Modulators from a Marine Cyanobacterium.
Al-Awadhi FH; Gao B; Rezaei MA; Kwan JC; Li C; Ye T; Paul VJ; Luesch H
J Med Chem; 2018 Jul; 61(14):6364-6378. PubMed ID: 30015488
[TBL] [Abstract][Full Text] [Related]
4. Design, Catalyst-Free Synthesis of New Novel α-Trifluoromethylated Tertiary Alcohols Bearing Coumarins as Potential Antifungal Agents.
Jiang S; Yang G; Shi L; Fan L; Pan Z; Wang C; Chang X; Zhou B; Xu M; Wu L; Xu C
Molecules; 2022 Dec; 28(1):. PubMed ID: 36615454
[TBL] [Abstract][Full Text] [Related]
5. Role of Kallikrein 7 in Body Weight and Fat Mass Regulation.
Kunath A; Weiner J; Krause K; Rehders M; Pejkovska A; Gericke M; Biniossek ML; Dommel S; Kern M; Ribas-Latre A; Schilling O; Brix K; Stumvoll M; Klöting N; Heiker JT; Blüher M
Biomedicines; 2021 Jan; 9(2):. PubMed ID: 33572949
[TBL] [Abstract][Full Text] [Related]
6. Trending Topics on Coumarin and Its Derivatives in 2020.
Carneiro A; Matos MJ; Uriarte E; Santana L
Molecules; 2021 Jan; 26(2):. PubMed ID: 33477785
[TBL] [Abstract][Full Text] [Related]
7. Natural and engineered kallikrein inhibitors: an emerging pharmacopoeia.
Swedberg JE; de Veer SJ; Harris JM
Biol Chem; 2010 Apr; 391(4):357-74. PubMed ID: 20180638
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of kallikrein-related peptidases: An overview.
Masurier N; Arama DP; El Amri C; Lisowski V
Med Res Rev; 2018 Mar; 38(2):655-683. PubMed ID: 28609548
[TBL] [Abstract][Full Text] [Related]
9. Insights into the activity control of the kallikrein-related peptidase 6: small-molecule modulators and allosterism.
Soualmia F; Bosc E; Amiri SA; Stratmann D; Magdolen V; Darmoul D; Reboud-Ravaux M; El Amri C
Biol Chem; 2018 Sep; 399(9):1073-1078. PubMed ID: 29641412
[TBL] [Abstract][Full Text] [Related]
10. Structure-based drug design to overcome species differences in kallikrein 7 inhibition of 1,3,6-trisubstituted 1,4-diazepan-7-ones.
Murafuji H; Sugawara H; Goto M; Oyama Y; Sakai H; Imajo S; Tomoo T; Muto T
Bioorg Med Chem; 2018 Jul; 26(12):3639-3653. PubMed ID: 29884582
[TBL] [Abstract][Full Text] [Related]
11. Pyrido-imidazodiazepinones as a new class of reversible inhibitors of human kallikrein 7.
Arama DP; Soualmia F; Lisowski V; Longevial JF; Bosc E; Maillard LT; Martinez J; Masurier N; El Amri C
Eur J Med Chem; 2015 Mar; 93():202-13. PubMed ID: 25682203
[TBL] [Abstract][Full Text] [Related]
12. Complex formation between human kallikrein 13 and serum protease inhibitors.
Kapadia C; Yousef GM; Mellati AA; Magklara A; Wasney GA; Diamandis EP
Clin Chim Acta; 2004 Jan; 339(1-2):157-67. PubMed ID: 14687906
[TBL] [Abstract][Full Text] [Related]
13. Structural basis for the Zn2+ inhibition of the zymogen-like kallikrein-related peptidase 10.
Debela M; Magdolen V; Bode W; Brandstetter H; Goettig P
Biol Chem; 2016 Dec; 397(12):1251-1264. PubMed ID: 27611765
[TBL] [Abstract][Full Text] [Related]
14. Structural Studies on the Inhibitory Binding Mode of Aromatic Coumarinic Esters to Human Kallikrein-Related Peptidase 7.
Hanke S; Tindall CA; Pippel J; Ulbricht D; Pirotte B; Reboud-Ravaux M; Heiker JT; Sträter N
J Med Chem; 2020 Jun; 63(11):5723-5733. PubMed ID: 32374603
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
